Die Sentinel-Node-Biopsie beim Mammakarzinom nach farbstoffinduzierter Lymphographie

Fragestellung: Material und Methode: Ergebnisse: Schlußfolgerung: Purpose: Material and Methods: Results: Discussion:

[1]  Peter M. Schlag,et al.  Axillaausräumung bei klinisch nodal-negativem Mammakarzinom: Kann die Indikation durch »sentinel node«-Nachweis individualisiert werden? , 2008 .

[2]  H. Cody,et al.  Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. , 1998, Journal of the American College of Surgeons.

[3]  P. V. van Diest,et al.  Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. , 1998, Journal of the American College of Surgeons.

[4]  M. Dorval,et al.  Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  A. Giuliano.  Intradermal blue dye to identify sentinel lymph node in breast cancer , 1997, The Lancet.

[6]  M. P. Moore,et al.  Axillary lymphadenectomy: A diagnostic and therapeutic procedure , 1997, Journal of surgical oncology.

[7]  A. Giuliano,et al.  Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. , 1997, Annals of surgery.

[8]  B. Cady.  Is Axillary Lymph Node Dissection Necessary in Routine Management of Breast Cancer? No. , 1997, Important advances in oncology.

[9]  Umberto Veronesi,et al.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes , 1997, The Lancet.

[10]  A E Giuliano,et al.  Sentinel lymphadenectomy in breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  L. Adler,et al.  Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET. , 1997, Radiology.

[12]  A Horsman,et al.  Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging. , 1997, Radiology.

[13]  M. R. Shetty,et al.  Tumor size and axillary metastasis, a correlative occurrence in 1244 cases of breast cancer between 1980 and 1995. , 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[14]  Theo Wiggers,et al.  Ultrasound-Guided Aspiration Biopsy for Detection of Nonpalpable Axillary Node Metastases in Breast Cancer Patients: New Diagnostic Method , 1997, World Journal of Surgery.

[15]  M. Cremonesi,et al.  Optimization of Axillary Lymphoscintigraphy to Detect the Sentinel Node in Breast Cancer , 1997, Tumori.

[16]  P. V. van Diest,et al.  Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  T. Yeatman,et al.  Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. , 1996, JAMA.

[18]  E. Rutgers,et al.  [The role of sentinel node biopsies in the treatment of patients with breast carcinoma]. , 1996, Nederlands tijdschrift voor geneeskunde.

[19]  M Schwaiger,et al.  Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. , 1996, Journal of the National Cancer Institute.

[20]  A. Giuliano,et al.  Incidence and predictors of axillary metastasis in T1 carcinoma of the breast. , 1996, Journal of the American College of Surgeons.

[21]  J. G. Schuler,et al.  The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. , 1996, Archives of surgery.

[22]  A. Giuliano,et al.  Improved Axillary Staging of Breast Cancer with Sentinel Lymphadenectomy , 1995, Annals of surgery.

[23]  M. Silverstein,et al.  Axillary lymph node dissection for t1a breast carcinoma. Is it indicated? , 1994, Cancer.

[24]  D. Weaver,et al.  Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. , 1993, Surgical oncology.

[25]  S. Michalas,et al.  Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach. , 1993, Oncology.

[26]  A. Lee,et al.  Occult axillary lymph node metastases in "node-negative" breast carcinoma. , 1993, Human pathology.

[27]  R. Isaacs,et al.  Role of computed tomography in the staging of primary breast cancer , 1993, The British journal of surgery.

[28]  J. Tjandra,et al.  Detection and significance of occult metastases in node‐negative breast cancer , 1993, The British journal of surgery.

[29]  J. Coindre,et al.  Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. , 1992, British Journal of Cancer.

[30]  G. Royle,et al.  Assessment of morbidity from complete axillary dissection. , 1992, British Journal of Cancer.

[31]  D L Morton,et al.  Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.

[32]  P. Deckers,et al.  Axillary dissection in breast cancer: When, why, how much, and for how long? Another operation soon to be extinct? , 1991, Journal of surgical oncology.

[33]  E. Marussi,et al.  Accuracy of ultrasound and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer. , 1991, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[34]  International Study Group,et al.  Prognostic importance of occult axillary lymph node micrometastases from breast cancers , 1990, The Lancet.

[35]  C. Carter,et al.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989, Cancer.

[36]  G. Royle,et al.  Ultrasound detection of axillary lymph node metastases in breast cancer. , 1989, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[37]  C. Redmond,et al.  The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. , 1981, Surgery, gynecology & obstetrics.

[38]  A. Wattiez,et al.  [Axillary lymphadenectomy by lipo-aspiration and endoscopic picking. Apropos of 72 cases]. , 1997, Chirurgie; memoires de l'Academie de chirurgie.

[39]  D W Kinne,et al.  Is axillary lymph node dissection necessary in the routine management of breast cancer? Yes. , 1996, Important advances in oncology.

[40]  D. Krag,et al.  Gamma-probe guided localization of lymph nodes. , 1993, Surgical oncology.

[41]  A. D. Schryver,et al.  Systemic treatment of early breast-cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31000 recurrences and 24000 deaths among 75000 women: 1 , 1992 .

[42]  O. Kosunen,et al.  Ultrasonographic detection of metastatic axillary lymph nodes in breast cancer. , 1990, Annales chirurgiae et gynaecologiae.

[43]  B. Brismar,et al.  Postoperative lymphoedema after treatment of breast cancer. , 1983, Acta chirurgica Scandinavica.